XBiotech Inc. (XBIT) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -8.97M | -22.95M | -4.26M | -5.99M | -6.72M | -6.54M | -5.84M | -11.38M | -7.2M | -3.43M | -1.49M | -9M | -4.81M | 2.7M | -1.15M | -5.39M | -5.12M | -1.76M | -3.4M | 72.8M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | 901% | -68.45% | -352.09% | -1024.6% | -39.09% | -75.28% | 1608.77% |
| Operating CF Growth % | -33.47% | -250.95% | 27.13% | 47.35% | 6.69% | -90.5% | -293.07% | -26.44% | -49.79% | -227.01% | -29.3% | -67.01% | 6.15% | 253.67% | 66.2% | -107.4% | -383.2% | -349.87% | -145.46% | 729.3% |
| Net Income | -5.5M | -26.89M | -6.01M | -1.76M | -10.88M | -10.51M | -5.01M | -13.01M | -10M | -4.63M | -7.36M | -8.74M | -3.82M | -3.2M | -12.66M | -11.64M | -5.39M | -6.47M | -3.26M | -5.12M |
| Depreciation & Amortization | 332K | 378K | 427K | 439K | 442K | 439K | 439K | 435K | 432K | 434K | 432K | 435K | 443K | 443K | 734K | 727K | 710K | 702K | 687K | 638K |
| Stock-Based Compensation | 0 | 0 | 24K | 107K | 3.33M | 628K | 365K | 379K | 381K | 688K | 955K | 914K | 705K | 1.04M | 1.13M | 1.45M | 1.45M | 1.35M | 1.13M | 1.04M |
| Deferred Taxes | 0 | 5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 1.3M | -1.01M | 1.2M | -3.08M | -284K | 4.1M | -707K | 554K | 1.58M | -1.25M | 1.06M | -1.33M | -383K | 2.8M | 4.88M | 990K | 0 | 0 | 0 | 0 |
| Working Capital Changes | -5.1M | 4.57M | 96K | -1.7M | 677K | -1.2M | -927K | 262K | 405K | 1.33M | 3.42M | -276K | -1.76M | 1.63M | 4.77M | 3.09M | -1.89M | 2.65M | -1.96M | 76.24M |
| Change in Receivables | 58K | 241K | 113K | 0 | 220K | 13K | 122K | -48K | -10K | 397K | 2.46M | -875K | -1.16M | 1.09M | 9.72M | -1.9M | -1.57M | 1.49M | -2.31M | 71.97M |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -678K | 492K | -385K | 330K | -1.13M | 653K | -200K | -825K | 8K | 1.03M | -320K | 444K | -1.06M | 1.1M | -962K | 1.03M | -812K | 1.17M | -653K | 383K |
| Cash from Investing | 9K | -34K | -110K | -51K | -94K | -84K | -338K | -627K | -255K | -115K | 61.83M | -208K | -6K | -3.91M | -59.74M | -82K | -161K | -476K | -700K | -1.71M |
| Capital Expenditures | 0 | -34K | -110K | -51K | -94K | -84K | -338K | -627K | -255K | -115K | -33K | -208K | -6K | -132K | -210K | -82K | -161K | -476K | -700K | -1.71M |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | 44% | 12.5% | 5.36% | 32.2% | 10.58% | 15.49% | 37.83% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 9K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 61.86M | 0 | 0 | 0 | -59.53M | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 0 | 0 | 0 | 0 | -10.25M | 283K | 64K | 48K | 10.05M | 0 | 5K | -14K | 0 | 0 | 0 | 0 | 0 | 33K | -72.04M | 3.98M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | -10.25M | 250K | 0 | 0 | 10M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 64K | 0 | 55K | 0 | 5K | 0 | 0 | 0 | 0 | 0 | 0 | 33K | 2.96M | 3.98M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -75M | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 33K | 0 | 48K | 0 | 0 | 0 | -14K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | -10.09M | -21.82M | -5.57M | -2.96M | -16.78M | -10.44M | -5.41M | -12.51M | 1.02M | -2.17M | 58.8M | -9.09M | -4.82M | -3.26M | -65.22M | -6.03M | -5.16M | -1.89M | -76.38M | 75.38M |
| Free Cash Flow | -8.97M | -22.99M | -4.37M | -6.04M | -6.81M | -6.62M | -6.18M | -12M | -7.46M | -3.55M | -1.52M | -9.21M | -4.81M | 2.57M | -1.36M | -5.47M | -5.28M | -2.23M | -4.1M | 71.08M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | 857% | -80.95% | -357.45% | -1056.8% | -49.67% | -90.77% | 1570.94% |
| FCF Growth % | -31.63% | -247.01% | 29.34% | 49.68% | 8.62% | -86.7% | -306.78% | -30.4% | -54.9% | -238% | -11.76% | -68.31% | 8.89% | 215.03% | 66.85% | -107.69% | -550.85% | 14.34% | -160.42% | 692.67% |
| FCF per Share | -0.29 | -0.75 | -0.14 | -0.20 | -0.22 | -0.22 | -0.20 | -0.39 | -0.24 | -0.12 | -0.05 | -0.30 | -0.16 | 0.08 | -0.04 | -0.18 | -0.18 | -0.07 | -0.14 | 2.37 |
| FCF Conversion (FCF/Net Income) | 1.63x | 0.85x | 0.71x | 3.41x | 0.62x | 0.62x | 1.17x | 0.87x | 0.72x | 0.74x | 0.20x | 1.03x | 1.26x | -0.84x | 0.09x | 0.46x | 0.95x | 0.27x | 1.04x | -14.22x |
| Interest Paid | 0 | 0 | 0 | 0 | 486K | 0 | 0 | -400K | 400K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |